Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert F Jacob

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Journal of the American College of Cardiology|November 16, 2004
Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease: a longitudinal analysis of the PREVENT studyMary F Walter, Robert F Jacob, Barrett Jeffers, et al.
Journal of Cardiovascular Pharmacology|June 21, 2006
Rofecoxib increases susceptibility of human LDL and membrane lipids to oxidative damage: a mechanism of cardiotoxicityR Preston Mason, Mary F Walter, Hyesun P McNulty, et al.
Pharmaceutical Research|December 19, 2007
Synergistic effect of amlodipine and atorvastatin in reversing LDL-induced endothelial dysfunctionR Preston Mason, Ruslan Kubant, Gehan Heeba, et al.
American Journal of Hypertension|September 5, 2009
Loss of arterial and renal nitric oxide bioavailability in hypertensive rats with diabetes: effect of beta-blockersR Preston Mason, Ruslan Kubant, Robert F Jacob, et al.
Thrombosis Research|August 24, 2010
Novel astaxanthin prodrug (CDX-085) attenuates thrombosis in a mouse modelSanjoy K Khan, Tadeusz Malinski, R Preston Mason, et al.
Molecular Genetics and Metabolism|July 5, 2011
Alterations in membrane caveolae and BKCa channel activity in skin fibroblasts in Smith-Lemli-Opitz syndromeGongyi Ren, Robert F Jacob, Yuri Kaulin, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Journal of the American College of Cardiology|November 16, 2004
Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease: a longitudinal analysis of the PREVENT studyMary F Walter, Robert F Jacob, Barrett Jeffers, et al.
Journal of Cardiovascular Pharmacology|June 21, 2006
Rofecoxib increases susceptibility of human LDL and membrane lipids to oxidative damage: a mechanism of cardiotoxicityR Preston Mason, Mary F Walter, Hyesun P McNulty, et al.
Pharmaceutical Research|December 19, 2007
Synergistic effect of amlodipine and atorvastatin in reversing LDL-induced endothelial dysfunctionR Preston Mason, Ruslan Kubant, Gehan Heeba, et al.
American Journal of Hypertension|September 5, 2009
Loss of arterial and renal nitric oxide bioavailability in hypertensive rats with diabetes: effect of beta-blockersR Preston Mason, Ruslan Kubant, Robert F Jacob, et al.
Thrombosis Research|August 24, 2010
Novel astaxanthin prodrug (CDX-085) attenuates thrombosis in a mouse modelSanjoy K Khan, Tadeusz Malinski, R Preston Mason, et al.
Molecular Genetics and Metabolism|July 5, 2011
Alterations in membrane caveolae and BKCa channel activity in skin fibroblasts in Smith-Lemli-Opitz syndromeGongyi Ren, Robert F Jacob, Yuri Kaulin, et al.
Pageof 4